UK Stocks-Factors to watch on May 19



May 19 (Reuters) - Futures for Britain's FTSE 100 index FFIc1 were 0.99% lower on Wednesday.

* ASTRAZENECA: The COVID-19 vaccine of AstraZeneca Plc AZN.L and Oxford University works well as a third booster dose, stepping up antibodies to the coronavirus spike protein among participants in a study, the Financial Times said.

* SHELL: Royal Dutch Shell RDSa.L is in talks with the Nigerian government to sell the Anglo-Dutch company's stake in onshore oilfields, CEO Ben van Beurden said on Tuesday.

* GOLD: Gold prices held steady near a four-month high helped by a weaker dollar, ahead of minutes from the U.S. Federal Reserve's last policy meeting that are expected to shed more light on policymakers' view on inflation.

* OIL: Oil prices fell on the potential of Iranian supply returning and as investors sold on speculation that inflation fears might lead the U.S. Federal Reserve to raise interest rates, which could limit economic growth.

* The UK blue-chip index .FTSE closed 0.02% higher on Tuesday as poor earnings by Vodafone offset gains in bank stocks, while better-than-expected jobs data strengthened views of a stronger economic recovery from a pandemic-driven crash last year.

* UK CORPORATE DIARY:

GPOR.L

Great Portland

FY results EXPN.L

Experian

FY results MARS.L

Marstons

HY results PFD.L

Premier Foods

FY results COA.L

Coats Group

Trading update

* For more on the factors affecting European stocks, please click on:

TODAY'S UK PAPERS

> Financial Times

> Other business headlines


Reporting by Priyanshi Mandhan in Bengaluru

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明